Literature DB >> 15498639

Tumour endothelial marker 8 (TEM-8) in human colon cancer and its association with tumour progression.

K A Rmali1, G Watkins, G Harrison, C Parr, M C A Puntis, W G Jiang.   

Abstract

BACKGROUND AND AIMS: Tumour endothelial marker-8 (TEM-8) is endothelial cell surface marker that may be specific to tumour endothelial cells. This study examined the role of TEM-8 in human colon cancer and its correlation with tumour prognosis.
METHODOLOGY: Specimens of colorectal tissue (normal and cancer) were stained immunohistochemically with an anti-TEM-8 antibody, newly developed in our laboratory, and with anti-vonWillebrand Factor antibody. RNA was extracted from frozen sections for gene amplification. The anti-TEM-8 antibody specificity tested by using slot blotting with irrelevant antibody, and western blotting with different cell lines. The expression of TEM-8 was assessed using RT-PCR, and the level of TEM-8 was quantified using real-time-quantitative PCR (Q-RT-PCR).
RESULTS: TEM-8 staining was primarily seen in endothelial cells. TEM-8 identified more micro-vessels in colon tumour tissue, than in normal colon tissues, (p=0.002). Whereas, fewer vessels were stained positive for TEM-8 in normal tissues stained positive for vonWillebrand Factor (factor-8), (p=0.008). Malignant cells in tumour tissues were found to be stained strongly positive for TEM-8 compared with the epithelial cells in normal colon tissues. The level of TEM-8 expression was significantly higher in the tumour tissues compared to the normal colon mucosa (p=0.001). TEM-8 mRNA expression was also found to be more elevated in patients with advanced tumour, Dukes C (Dukes A vs. Dukes C, p=0.01).
CONCLUSION: TEM-8 is a marker that identifies tumour associated micro-vessels in colon cancer. The levels of expression of TEM-8 in invasive colon cancer are linked to disease progression. This suggests that TEM-8 has significant prognostic and therapeutic values in colon cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15498639     DOI: 10.1016/j.ejso.2004.07.023

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  12 in total

1.  Anti-tumor angiogenesis effect of genetic fusion vaccine encoding murine beta-defensin 2 and tumor endothelial marker-8 in a CT-26 murine colorectal carcinoma model.

Authors:  Ping Liu; Ganfeng Xie; Peiliang Geng; Chenhong Zheng; Jianjun Li; Feng Pan; Zhihua Ruan; Houjie Liang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 2.  Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment.

Authors:  Alain E Andrea; Andrada Chiron; Sarah Mallah; Stéphanie Bessoles; Guillaume Sarrabayrouse; Salima Hacein-Bey-Abina
Journal:  Front Immunol       Date:  2022-02-08       Impact factor: 7.561

3.  Prognostic value of tumour endothelial markers in patients with endometrial cancer.

Authors:  Nick A Bersinger; Brigitte Schneider; Stephan A Vorburger; Silke Johann; Daniel Candinas; Michael D Mueller
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

4.  Capillary morphogenesis gene 2 inhibits growth of breast cancer cells and is inversely correlated with the disease progression and prognosis.

Authors:  Lin Ye; Ping-Hui Sun; Muhammad Faraz Arshad Malik; Malcolm D Mason; Wen G Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-26       Impact factor: 4.553

5.  A FRET-based high throughput screening assay to identify inhibitors of anthrax protective antigen binding to capillary morphogenesis gene 2 protein.

Authors:  Michael S Rogers; Lorna M Cryan; Kaiane A Habeshian; Lauren Bazinet; Thomas P Caldwell; P Christine Ackroyd; Kenneth A Christensen
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

6.  ANTXR1 Is a Prognostic Biomarker and Correlates With Stromal and Immune Cell Infiltration in Gastric Cancer.

Authors:  Xiaodong Huang; Jie Zhang; Yongbin Zheng
Journal:  Front Mol Biosci       Date:  2020-12-15

7.  Clinical Value of Detecting Tumor Endothelial Marker 8 (ANTXR1) as a Biomarker in the Diagnosis and Prognosis of Colorectal Cancer.

Authors:  Łukasz Pietrzyk; Agnieszka Korolczuk; Małgorzata Matysek; Marcin B Arciszewski; Kamil Torres
Journal:  Cancer Manag Res       Date:  2021-04-09       Impact factor: 3.989

8.  Tumour endothelial marker-8 in wound healing and its impact on the proliferation and migration of keratinocytes.

Authors:  Sheila C Wang; Lin Ye; Andrew J Sanders; Fiona Ruge; Keith G Harding; Wen G Jiang
Journal:  Int J Mol Med       Date:  2015-12-11       Impact factor: 4.101

9.  In situ targeting TEM8 via immune response and polypeptide recognition by wavelength-modulated surface plasmon resonance biosensor.

Authors:  Yimin Wang; Zewei Luo; Kunping Liu; Jie Wang; Yixiang Duan
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

Review 10.  Biomarkers Discovery for Colorectal Cancer: A Review on Tumor Endothelial Markers as Perspective Candidates.

Authors:  Łukasz Pietrzyk
Journal:  Dis Markers       Date:  2016-11-14       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.